Baystate Wealth Management’s Inspire Medical Systems INSP Stock Holding History

Baystate Wealth Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$9.13K	Hold	44	–	–	﹤0.01%	744
2023 Q3	$8.91K	Hold	44	–	–	﹤0.01%	601
2023 Q2	$14.6K	Hold	44	–	–	﹤0.01%	504
2023 Q1	$10.5K	Hold	44	–	–	﹤0.01%	556
2022 Q4	$11K	Hold	44	–	–	﹤0.01%	555
2022 Q3	$8K	Hold	44	–	–	﹤0.01%	581
2022 Q2	$8K	Hold	44	–	–	﹤0.01%	603
2022 Q1	$12K	Hold	44	–	–	﹤0.01%	545
2021 Q4	$10K	Buy	+44	New	+$10.7K	﹤0.01%	575

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Baystate Wealth Management's INSP Position: Q4 2023 in Review

Baystate Wealth Management held its Inspire Medical Systems (INSP) position steady in Q4 2023 at 44 shares worth $9.13K. The position accounts for ﹤0.01% of the portfolio, ranked #744.

Baystate Wealth Management first reported a position in INSP in Q4 2021 and has held it in 9 quarters since. The position peaked at $14.6K in Q2 2023. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

Baystate Wealth Management held 44 shares of Inspire Medical Systems worth $9.13K as of Q4 2023.
Baystate Wealth Management left its Inspire Medical Systems share count unchanged in Q4 2023.
Inspire Medical Systems made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #744 holding.
Baystate Wealth Management first reported a position in Inspire Medical Systems in Q4 2021 and has held it in 9 quarters since.
Baystate Wealth Management's Inspire Medical Systems position peaked at $14.6K in Q2 2023.
343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.